Altered splenic [(89)Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism?

Rituximab (RTX) for immune-mediated inflammatory disease (IMID) with interstitial pneumonitis (IP) results in non-response in about a third of patients for reasons not well understood. Complete peripheral B-cell depletion in IMID-IP does not seem to correlate with successful treatment outcome. A hyp...

Full description

Saved in:
Bibliographic Details
Published in:Am J Nucl Med Mol Imaging
Main Authors: Adams, Human, Meek, Bob, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, Keijsers, Ruth G, Grutters, Jan C
Format: Artigo
Language:Inglês
Published: e-Century Publishing Corporation 2020
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486548/
https://ncbi.nlm.nih.gov/pubmed/32929395
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items